Lattuada, E., et al. “Optimal Fosamprenavir Regimen to Prevent Lipid Abnormalities”. Acta Biomedica Atenei Parmensis, vol. 80, no. 3, Dec. 2009, pp. 200-2, https://mattioli1885journals.com/index.php/actabiomedica/article/view/1171.